% of shares outstanding not shown: this line files 20-F annual reports only — a foreign private issuer whose US listing trades as ADSs (depositary receipts), while its cover-page share count is in ORDINARY shares. The depositary ratio is not in our data. The count we hold for this line is 39,339,960 shares (as of 2025-12-31, source dei). Dividing one by the other is wrong by the whole ratio (a 5:1 ADR reads one fifth of the true percentage), so the percentage is withheld rather than served wrong. Holder share counts are shown as filed.
Crowding percentile withheld — no market cap for BLTE in the served universe — the cohort is size-matched, and an unmatched percentile would compare a micro-cap register to a mega-cap one.
Ranked by each filer’s own reported value, not shares.
| Biggest buyers | Δ shares | Δ value | |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | +1,114,784 | $178M | OPEN |
| UBS Group AG | +639,607 | $102M | ADD |
| Holocene Advisors, LP | +410,428 | $65M | ADD |
| PRICE T ROWE ASSOCIATES INC /MD/ | +281,805 | $45M | OPEN |
| MORGAN STANLEY | +173,396 | $28M | ADD |
| Biggest sellers | Δ shares | Δ value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | −432,484 | $69M | CLOSE |
| Point72 Asset Management, L.P. | −284,437 | $45M | CLOSE |
| PERCEPTIVE ADVISORS LLC | −262,260 | $42M | TRIM |
| MARSHALL WACE, LLP | −192,700 | $31M | CLOSE |
| Western Standard LLC | −60,026 | $10M | CLOSE |
Prior quarter split-rebased · 13Fs are long, US-listed only.
| Holder | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | — | — | — | — | 3.0M | 3.1M | $456M |
| Paradigm Biocapital Advisors LP | — | — | — | — | — | 1.1M | $178M |
| UBS Group AG | 12K | 551 | 2K | 11K | 129K | 768K | $123M |
| RTW INVESTMENTS, LP | — | — | — | 313K | 715K | 715K | $114M |
| MILLENNIUM MANAGEMENT LLC | — | — | — | 21K | 559K | 570K | $91M |
| Holocene Advisors, LP | — | — | — | — | 84K | 494K | $79M |
| EVENTIDE ASSET MANAGEMENT, LLC | — | — | — | 195K | 383K | 358K | $57M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | — | — | — | — | 234K | 304K | $48M |
| PRICE T ROWE ASSOCIATES INC /MD/ | — | — | — | — | — | 282K | $45M |
| MORGAN STANLEY | 11K | 316 | 507 | 5K | 28K | 201K | $32M |
| PERCEPTIVE ADVISORS LLC | — | — | — | 50K | 414K | 152K | $24M |
| Patient Square Capital LP | — | — | — | — | — | 117K | $19M |
| Duquesne Family Office LLC | — | — | — | — | — | 106K | $17M |
| GOLDMAN SACHS GROUP INC | 6K | — | — | 4K | 45K | 106K | $17M |
| MPM BIOIMPACT LLC | — | — | — | — | 88K | 88K | $14M |
Green = added, red = trimmed, grey = held; a dash is a quarter with no 13F on file — a gap, not an exit.
Holders only — breaks = no 13F.
Short interest has its own tab now — open SI →
SEC Form 13F · ~10,250 filers, 10y · long-only, US-listed, filed ≤45d after quarter-end.